Clinical and demographic features of infection caused by Acinetobacter species

Indian Journal of Medical Sciences

Volumn 60, Issue 9, 2006, Pages 351-360

  Joshi, Suresh ^a,c   Litake, Geetanjali ^b   Satpute, Meenakshi ^a   Telang, Nilima ^a   Ghole, Vikram ^b   Niphadkar, Krishna ^a  

^a King Edward Memorial Hospital   (India)

^b UNIVERSITY OF PUNE   (India)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acinetobacter; Antimicrobial resistance; Hospital acquired infection; Nosocomial pathogen; Risk factor

Indexed keywords

AMIKACIN; AMOXICILLIN; CEFAZOLIN; CEFOPERAZONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; NETILMICIN; OXYTETRACYCLINE; PIPERACILLIN; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD; CEREBROSPINAL FLUID; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESISTANCE; FECES; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; MALE; MICROORGANISM DETECTION; MORTALITY; NEWBORN; PUS; SCHOOL CHILD; SPECIES DIFFERENTIATION; SPUTUM; TERTIARY HEALTH CARE; URINARY TRACT INFECTION; URINE; WOUND INFECTION;

EID: 33748561163     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.27219     Document Type: Article

References (32)

1. Koprnova J, Svetlansky I, Babel AR, Bilikova E, Hanzen J, Zuscakova IJ, et al. Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia. Scand J Infect Dis 2001;33:891-5.
2. Lahiri KK, Mani NS, Purai SS. Acinetobacter spp. as nosocomial pathogens: Clinical significance and antimicrobial sensitivity. Med J Armed Forces India (MJAFI) 2004;60:7-10.
3. Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. J Med Microbiol 1997;6:186-97.
4. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006;129:102-9.
5. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, et al. Epidemiology and infection control implication of Acinetobacter spp. in Hong Kong. J Clin Microbiol 2001;39:228-34.
6. Von Graevenitz A. Acinetobacter, Alcaligenes, Moraxella and other non-fermentative gram-negative bacteria. In: Manual of clinical microbiology. Murray PJ, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. American Society of Microbiology: Washington DC; 1995. p. 520-32.
7. Juni E. Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol 1972;112:917-31.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
9. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987;138:569-78.
10. th information supplement. NCCLS documents. NCCLS: Villanova, PA; 1994. p. M100-S5.
11. National Committee for Clinical Laboratory Standards (now Clinical and Laboratory Standards Institute, CLSI). Methods for dilution antimicrobial susceptibility testing for bacteria that grows aerobically. Approved Standards M7-A4. Villanova, PA: NCCLS, 1997.
12. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C, Barrero-Almodovar AE, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study. Clin Infect Dis 2001;33:939-46.
13. Joshi SG. Assignment of antibiotic resistance to a naturally occurring plasmid in clinical isolates of Acinetobacter. Ph.D. thesis. Faculty of Medicine, University of Pune: India; 1998.
14. Arora U, Jaitwani J. Acinetobacter spp: An emerging pathogen in neonatal septicemia in Amritsar. Indian J Med Microbiol 2006;24:81.
15. Prashanth K, Badrinath S. Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors. Indian J Med Microbiol 2006;24:39-44.
16. Christie C, Mazon D, Hierholzer W Jr, Patterson JE. Molecular heterogeneity of Acinetobacter baumannii isolates during seasonal increase in prevalence. Infect Control Hosp Epidemiol 1995;16:590-4.
17. Yu YS, Yang Q, Xu XW, Kong HS, Xu GY, Zhong BY. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol 2004;53:653-6.
18. Cisneros JM, Rodriguez-Bario J. Nosocomial bacteremia due to Acinetobacter baumannii: Epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93.
19. Moreno S, Vicente T, Armas M, Bernaldo de Quiros JC, Rodriguez-Creixems M, Bouza E. Nosocomial bacteremia caused by Acinetobacter. Enferm Infecc Microbiol Clin 1990;8:606-9.
20. Agodi A, Zarrilli R, Barelitta M, Anzaldi A, Di Popolo A, Mattaliano A, et al. Alert surveillance of intensive care unit-acquired Acinetobacter infection in a Sicillian hospital. Clin Microbiol Infect 2006;12:241-7.
21. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multi-resistant Acinetobacter baumannii risk factors and prognosis. Clin Infect Dis 1995;20:790-6.
22. von Dolinger de Brito D, Oliveira EJ, Abdallah VO, da Costa Darini AL, Gontijo Filho PP. An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil. Braz J Infect Dis 2005;9:301-9.
23. st century approach. Clin Infect Dis 2002;34:1564-7.
24. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multi-drug resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82.
25. Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study. Antimicrob Agents Chemother 2004;48:224-8.
26. Murray CK, Hospenthal DR. Treatment of multi-drug resistant Acinetobacter. Curr Opin Infect Dis 2005;18:502-6.
27. Chen HP, Chen TL, Lai CH, Fung CP, Wong WW, Yu KW, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005;38:127-36.
28. Martinez-Martinez L, Rodriguez G, Pascual A, Suarez AI, Perea EJ. In vitro activity of antimicrobial agent combinations against multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 1996;38:1107-8.
29. Lee SY, Kuti JL, Nicolau DP. Polymyxins: Older antibiotics for a new threat. Conn Med 2006;70:25-8.
30. Joshi SG, Litake GM, Ghole VS, Niphadkar KB. Plasmid-borne extended-spectrum β-lactamase in a clinical isolate of Acinetobacter baumannii. J Med Microbiol 2003;52:1125-7.
31. Joshi SG, Litake GM, Ghole VS, Niphadkar KB. Fluoroquinolone resistance from a transferable plasmid in Acinetobacter calcoaceticus. Indian J Pathol Microbiol 2004;47:593-4.
32. Tankovic J, Legrard P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994;32:2677-81.